Showing results (851-860 of 5,208) with videos related to

Sort By:
Pageof 521
Occupational Therapy in Health Care|December 6, 2021
Dual-Task Training Combining Cognitive Tasks and Occupations among Japanese Community-Dwelling Older Adults: A Pilot StudyK Yokoi, Y Sakakibara, T Inamoto, et al.
Iscience|January 25, 2021
Responsibility of consumers for mining capacity: decomposition analysis of scarcity-weighted metal footprints in the case of JapanRyosuke Yokoi, Keisuke Nansai, Kenichi Nakajima, et al.
Sensors (Basel, Switzerland)|August 16, 2019
Design and Implementation of Arch Function for Adaptive Multi-Finger Prosthetic HandXu Yong, Xiaobei Jing, Xinyu Wu, et al.
Journal of Inorganic Biochemistry|August 17, 2019
Design, synthesis, and anticancer activity of iridium(III) complex-peptide hybrids that contain hydrophobic acyl groups at the N-terminus of the peptide unitsKana Naito, Kenta Yokoi, Chandrasekar Balachandran, et al.
Oral Diseases|September 17, 2022
Experimental tooth loss affects spatial learning function and blood-brain barrier of miceHiroshi Oue, Rie Hatakeyama, Eri Ishida, et al.
Life Sciences|January 1, 1988
Formation of 2-guanidinoethanol by a transamidination reaction from arginine and ethanolamine by the rat kidney and pancreasY Watanabe, I Yokoi, S Watanabe, et al.
Human Genome Variation|May 22, 2020
Tatton-Brown-Rahman syndrome with a novel DNMT3A mutation presented severe intellectual disability and autism spectrum disorderTakayuki Yokoi, Yumi Enomoto, Takuya Naruto, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Activities of cytochrome p450 enzymes in liver and kidney microsomes from systemic carnitine deficiency mice with a gene mutation of carnitine/organic cation transporterHiroshi Yamazaki, Hitomi Iketaki, Ayaka Shibata, et al.
Toxicology Letters|August 9, 2006
Dephosphorylation of ribosomal protein P0 in response to troglitazone-induced cytotoxicityRawiwan Maniratanachote, Keiichi Minami, Miki Katoh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1991
[Five-day continuous infusion of vindesine in the treatment of non-small cell lung cancer--clinical pharmacokinetics of vindesine]Y Saito, K Mori, K Tominaga, et al.
Pageof 521